Randomized controlled trial to examine an effect of the Rikkunshito for stasis of post-gastrectomy

Randomized controlled trial to examine an effect of the Rikkunshito for stasis of post-gastrectomy - Rikkunshito trial for stasis of post-gastrectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030827

Enrollment

Registered

2018-01-15

Start date

2017-11-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Medication of rikkunshi-to, 4-weeeks, 7.5g/day no-treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Patients who had undergone distal or pylorus preserved gastrectomy 2 Patients with gastric cancer from clinical Stage IA to IIIC 3 ECOG Performance Status of 0 or 1 4 The cases that an agreement was obtained after enough explanation

Exclusion criteria

Exclusion criteria: 1 Patients who are receiving chemotherapy 2 Patients who had received neoadjuvant chemotherapy 3)Multiple primary cancers 4 Patients with complicated resection excluding cholecystectomy 5 Patients who had done intestinal resection 6 Severe complication of circulatory organ respiratory apparatus liver kidney AST or ALT are exceed 2.5 times of the institution reference value Cr 2.0mg/dL over HbA1c 7.0% over 7 Received medications which affect the gut hormones,Daikenchu-to Chinpi Liraglutide capromorelin etc 8 Other patients inappropriate for this study in the opinion of the investigator

Design outcomes

Primary

Measure	Time frame
The improvement in the quality of life (QOL) by questionnaire after therapy	—

Countries

Japan

Contacts

Public ContactKano Mikihiro

Hiroshima City Asa Citizens Hospital Department of Surgery

mkanou0911@yahoo.co.jp082-815-5211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026